Blog | HemaCare

Engineering Hematopoietic Stem Cells for a One-Two Punch of Cancer Immunotherapy

Mar 26, 2014 6:16:13 AM / by Maria posted in PBCs, Cancer, Cell Therapy, Drug Discovery, leukemia, lymphoma, Peripheral blood cells, Stem Cell Therapy, Stem Cells, T Cells, Basic Research, Immunotherapy (Immunology)

0 Comments

In Part I of this series we introduced T cell based immunotherapy and in Part II we discussed how chimeric antigen receptors (CARs) expressing T cells can be even more potent. In Part III below, we expand this concept further by covering hematopoetic stem cells and additional ways they can be engineered for promising immunotherapy of cancer and leukemia.

Read More

Will T Cells Be the Future Basis of Cancer Therapy?

Mar 12, 2014 6:00:07 AM / by Maria posted in PBCs, antibodies, Bone Marrow, Cancer, Cell Therapy, Cord Blood, Drug Discovery, PBMCs, Peripheral blood cells, Stem Cell Therapy, Stem Cells, T Cells, T lymphocytes, Tumors, Basic Research, Immunotherapy (Immunology)

0 Comments

Recent data suggest that the average person has about a 40% chance of developing cancer at some point in his or her lifetime. [1] If those statistics are not frightening enough, let’s talk treatment: chemotherapy, radiation, surgery, chemical-based drug therapy, or a combination of the above. And don’t forget the various side effects of cancer therapy, many of which are a result of the destruction of crucial adult stem cells in the body. Because of this, stem cell transplants have been performed with fresh stem cells originating from bone marrow, peripheral blood, or cord blood to help replenish a patient’s hematopoietic system.

Read More

Drug Screening in Healthy and Diseased PBMCs

Jan 22, 2014 2:32:37 PM / by Maria posted in drug screening, PBCs, proliferation, apoptosis, Drug Discovery, infection, Inflammation, migration, PBMCs, Peripheral blood cells, viability, Basic Research

0 Comments

Peripheral Blood Mononuclear Cells (PBMCs) can be used in drug screening.  In Part I from this series, we discussed how they can be used to assay drug activity including effects on proliferation, viability, apoptosis, inflammation, and migration in healthy and disease cell models.  There are related assays available to measure the effects of drug treatment and, especially for researchers that prefer to use human samples, peripheral blood mononuclear cells are often the cells of choice (PBMCs) are often the cells of choice.  The advantages of using human cells initially are immense.

Read More

Peripheral Blood Mononuclear Cells in Drug Discovery and Development

Jan 14, 2014 7:00:10 AM / by Maria posted in drug screening, Drug Discovery, PBMCs, Peripheral blood cells, Basic Research

0 Comments

Use of human samples including peripheral blood mononuclear cells (PBMCs) in drug discovery is critical for increasing the chances of success for a small molecule screen hit. This is the first in a four part series on peripheral blood mononuclear cells and their use in drug discovery.

Read More

Bipolar Disorder in Your Blood?

Jan 10, 2014 12:30:01 PM / by Maria posted in Assay Development, Drug Discovery, Peripheral blood cells, Basic Research

0 Comments

Physiological Characteristics in Patients with Bipolar Disease May Open Doors for New Therapies

Read More

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts